| Style | Citing Format |
|---|---|
| MLA | Azimi SZ, et al.. "Treatment Concerns for Bullous Pemphigoid in the Covid-19 Pandemic Era." Dermatologic Therapy, vol. 33, no. 6, 2020, pp. -. |
| APA | Azimi SZ, Firooz A, Murrell DF, Daneshpazhooh M (2020). Treatment Concerns for Bullous Pemphigoid in the Covid-19 Pandemic Era. Dermatologic Therapy, 33(6), -. |
| Chicago | Azimi SZ, Firooz A, Murrell DF, Daneshpazhooh M. "Treatment Concerns for Bullous Pemphigoid in the Covid-19 Pandemic Era." Dermatologic Therapy 33, no. 6 (2020): -. |
| Harvard | Azimi SZ et al. (2020) 'Treatment Concerns for Bullous Pemphigoid in the Covid-19 Pandemic Era', Dermatologic Therapy, 33(6), pp. -. |
| Vancouver | Azimi SZ, Firooz A, Murrell DF, Daneshpazhooh M. Treatment Concerns for Bullous Pemphigoid in the Covid-19 Pandemic Era. Dermatologic Therapy. 2020;33(6):-. |
| BibTex | @article{ author = {Azimi SZ and Firooz A and Murrell DF and Daneshpazhooh M}, title = {Treatment Concerns for Bullous Pemphigoid in the Covid-19 Pandemic Era}, journal = {Dermatologic Therapy}, volume = {33}, number = {6}, pages = {-}, year = {2020} } |
| RIS | TY - JOUR AU - Azimi SZ AU - Firooz A AU - Murrell DF AU - Daneshpazhooh M TI - Treatment Concerns for Bullous Pemphigoid in the Covid-19 Pandemic Era JO - Dermatologic Therapy VL - 33 IS - 6 SP - EP - PY - 2020 ER - |